• Jayaswal Rp Department of Medical Laboratory Technology, Amity Medical School, Amity University, Haryana, India-122413.
  • Vijayasimha M Department of Medical Laboratory Technology, Amity Medical School, Amity University, Haryana, India-122413.
  • Prabhakar Pk Department of Medical Laboratory Sciences, Lovely Professional University, Phagwara, Punjab, India-144411



Type 1 diabetes, Type 2 diabetes, Microbiome, Microbiota, Symbiont, Probiotics, Prebiotics, Complications



 In recent years, the curiosity to investigate the relationship between gut microbiota and diabetes development has increased. Evidence from previous studies suggests that gut microbiota manipulation may assure to prevent diabetes development in future, primarily in susceptible individuals. Here, we reviewed special gut microbiota types proposing development of Type 1 (T1D) and Type 2 diabetes (T2D) in humans and laboratory animals. The available data we found are still inconclusive and required more attention in discriminating specific groups of gut microbiomes strongly indicating T1D and T2D development or prevention. Further, we suggested for the first time to study the gut microbiota in different ways to find the root cause of diabetes development.


Download data is not yet available.


Satish CS. Formulation and evaluation of a chitosan-PVA-gellan insulin implant. Int J App Pharm 2017; 9: 37-41.

Rupeshkumar M, Kavitha K, Haldar PK. Role of herbal plants in the diabetes mellitus therapy: an overview. Int J App Pharm 2014;6:1-3.

Tai N, Wong FS, Wen L. The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity. Rev Endocr Metab Disord 2015;16:55-65.

Stachowicz N, Kiersztan A. The role of gut microbiota in the pathogenesis of obesity and diabetes. Postepy Hig Med Dosw (Online) 2012;67:288-303.

Nielsen DS, Krych L, Buschard K, Hansen CH, Hansen AK. Beyond genetics. Influence of dietary factors and gut microbiota on type 1 diabetes. FEBS letters 2014;588:4234-43.

Vaarala O, Atkinson MA, Neu J. The Perfect Storm†for type 1 diabetes. Diabetes 2008;57:2555-62.

Musso G, Gambino R, Cassader M. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care 2010;33:2277-84.

Musso G, Gambino R, Cassader M. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med 2011;62:361-80.

Atkinson MA, Chervonsky A. Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease. Diabetologia 2012;55:2868-77.

Vaarala O. Gut microbiota and type 1 diabetes. Rev Diabet Stud 2012;9:251-59.

Zipris D. The interplay between the gut microbiota and the immune system in the mechanism of type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 2013;20:265-70.

Gomes AC, Bueno AA, de Souza RGM, Mota JF. Gut microbiota, probiotics and diabetes. Nutr J 2014;13:60.

Naseer MI, Bibi F, Alqahtani MH, Chaudhary AG, Azhar EI, Kamal MA et al. Role of gut microbiota in obesity, type 2 diabetes and Alzheimer’s disease. CNS Neurol Disord Drug Targets 2014;13:305-11.

Alam M, Alam Q, Kamal MA, Abuzenadah AM, Haque A. A possible link of gut microbiota alteration in type 2 diabetes and Alzheimer’s disease pathogenicity: an update. CNS Neurol Disord Drug Targets 2014;13:383-90.

Allin KH, Nielsen T, Pedersen O. Mechanisms in endocrinology: Gut microbiota in patients with type 2 diabetes mellitus. Eur J Endocrinol 2015;172:R167-77.

Sun J, Furio L, Mecheri R, van der Does AM, Lundeberg E, Saveanu L, et al. Pancreatic β-cells limit autoimmune diabetes via an immunoregulatory antimicrobial peptide expressed under the influence of the gut microbiota. Immunity 2015;43:304-17.

Pushpanathan P, Srikanth P, Seshadri KG, Selvarajan S, Pitani RS, Kumar TD, et al. Gut microbiota in type 2 diabetes individuals and correlation with monocyte chemoattractant protein1 and interferon gamma from patients attending a tertiary care Centre in Chennai, India. Indian J Endocrinol Metab 2016;20:523-30.

Hu C, Wong FS, Wen L. Type 1 diabetes and gut microbiota: Friend or foe? Pharmacol Res 2015;98:9-15.

Wang F, Zhang C, Zeng Q. Gut microbiota and immunopathogenesis of diabetes mellitus type 1 and 2. Front Biosci (Landmark Ed) 2016;21:900-6.

He C, Shan Y, Song W. Targeting gut microbiota as a possible therapy for diabetes. Nutr Res 2015;35:361-7.

Ho J, Reimer RA, Doulla M, Huang C. Effect of prebiotic intake on gut microbiota, intestinal permeability and glycemic control in children with type 1 diabetes: study protocol for a randomized controlled trial. Trials 2016;17:347.

Patterson E, Ryan PM, Cryan JF, Dinan TG, Ross RP, Fitzgerald al. Gut microbiota, obesity and diabetes. Postgrad Med J 2016;92:286-300.

Hu Y, Wong FS, Wen L. Antibiotics, gut microbiota, environment in early life and type 1 diabetes. Pharmacol Res 2017;119:219-26.

Saad MJ, Santos A, Prada PO. Linking gut microbiota and inflammation to obesity and insulin resistance. Physiology (Bethesda) 2016;31:283-93.

Kootte RS, Vrieze A, Holleman F, Dallinga-Thie GM, Zoetendal EG, de Vos WM. et al. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes, Obes Metab 2012;14:112-20.

Xu J, Lian F, Zhao L, Zhao Y, Chen X, Zhang X et al. Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula. ISME J 2015;9:552-62.

Sasaki M, Ogasawara N, Funaki Y, Mizuno M, Iida A, Goto C et al. Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study. BMC gastroenterol 2013;13:81.

Bajaj JS, Betrapally NS, Hylemon PB, Thacker LR, Daita K, Kang DJ et al. Gut microbiota alterations can predict hospitalizations in cirrhosis independent of diabetes mellitus. Sci Rep 2015; 5:18559.

Wirth R, Bódi N, Maróti G, Bagyánszki M, Talapka P, Fekete É et al. Regionally distinct alterations in the composition of the gut microbiota in rats with streptozotocin-induced diabetes. PloS one 2014;9:e110440.

Stewart CJ, Nelson A, Campbell MD, Walker M, Stevenson EJ, Shaw JA et al. Gut microbiota of Type 1 diabetes patients with good glycaemic control and high physical fitness is similar to people without diabetes: an observational study. Diabet Med 2017;34:127-34.

Soyucen E, Gulcan A, Aktuglu-Zeybek AC, Onal H, Kiykim E, Aydin A. Differences in the gut microbiota of healthy children and those with type 1 diabetes. Pediatr Int 2014;56:336-43.

Serino M, Blasco-Baque V, Burcelin R. Microbes on-air: gut and tissue microbiota as targets in type 2 diabetes. J Clin Gastroenterol 2012;46:S27-8.

Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012;490:55-60.

Puddu A, Sanguineti R, Montecucco F, Viviani GL. Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes. Mediators Inflamm 2014;2014:162021.

Peng J, Narasimhan S, Marchesi JR, Benson A, Wong FS, Wen L. Long term effect of gut microbiota transfer on diabetes development. J Autoimmun 2014;53:85-94.

Murphy R, Tsai P, Jüllig M, Liu A, Plank L, Booth M. Differential changes in gut microbiota after gastric bypass and sleeve gastrectomy bariatric surgery vary according to diabetes remission. Obes Surg 2017;27:917-25.

Mei X, Zhang X, Wang Z, Gao Z, Liu G, Hu H et al. Insulin sensitivity-enhancing activity of Phlorizin is associated with lipopolysaccharide decrease and gut microbiota changes in obese and type 2 diabetes (db/db) mice. J Agric Food Chem 2016;64:7502-11.

McPhee JB, Schertzer JD. Immunometabolism of obesity and diabetes: microbiota link compartmentalized immunity in the gut to metabolic tissue inflammation. Clin Sci (Lond) 2015;129:1083-96.

Li D, Kirsop J, Tang WW. Listening to our gut: contribution of gut microbiota and cardiovascular risk in diabetes pathogenesis. Curr Diab Rep 2015;15:63.

Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PloS one 2010;5:e9085.

Murri M, Leiva I, Gomez-Zumaquero JM, Tinahones FJ, Cardona F, Soriguer F et al. Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med 2013;11:46.

Muñoz-Garach A, Diaz-Perdigones C, Tinahones FJ. Gut microbiota and type 2 diabetes mellitus. Endocrinol Nutr 2016;63:560-8.

Moreno-Indias I, Cardona F, Tinahones FJ, Queipo-Ortuño MI. Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Front Microbiol 2014;5:190.

Miele L, Giorgio V, Alberelli MA, De Candia E, Gasbarrini A, Grieco A. Impact of gut microbiota on obesity, diabetes, and cardiovascular disease risk. Curr Cardio Rep 2015;17:120.

Lau E, Carvalho D, Pina-Vaz C, Barbosa JA, Freitas P. Beyond gut microbiota: understanding obesity and type 2 diabetes. Hormones (Athens) 2015;14:358-69.

Gülden E, Wong FS, Wen L. The gut microbiota and type 1 diabetes. Clin Immunol 2015;159:143-53.



How to Cite

Rp, J., V. M, and P. Pk. “GUT MICROBIOTA AND DIABETES MELLITUS - AN INTERLINKAGE”. Asian Journal of Pharmaceutical and Clinical Research, vol. 11, no. 1, Jan. 2018, pp. 13-16, doi:10.22159/ajpcr.2018.v11i1.22305.



Review Article(s)